EPISODE · Jan 9, 2025 · 4 MIN
When Drug Reps Visit: Darshan Reacts
from DarshanTalks Podcast · host Darshan Kulkarni
Send us Fan MailDarshan reacts to a fake interaction between a drug sales representative and a doctor. He shares insights on pharmaceutical marketing tactics, highlighting that while doctors often find sales reps personable, they may not trust them as much as medical science liaisons (MSLs) due to limitations on what reps can legally discuss about drugs. Darshan explains industry regulations, such as the Pharma Code and the Sunshine Act, which restrict certain gifts to avoid conflicts of interest. He also critiques exaggerated claims by reps, such as new drugs having unprecedented benefits without comparative studies, stressing that the FDA requires rigorous evidence.Support the showwww.kulkarnilawfirm.com
Embed this episode
What this episode covers
Send us Fan Mail Darshan reacts to a fake interaction between a drug sales representative and a doctor. He shares insights on pharmaceutical marketing tactics, highlighting that while doctors often find sales reps personable, they may not trust them as much as medical science liaisons (MSLs) due to limitations on what reps can legally discuss about drugs. Darshan explains industry regulations, such as the Pharma Code and the Sunshine Act, which restrict certain gifts to avoid conflicts of int...
NOW PLAYING
When Drug Reps Visit: Darshan Reacts
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.